Stuart R. Lessin, M.D. is a board certified dermatologist with over 25 years of laboratory and clinical research experience. At the University of Pennsylvania (1987-2000), he investigated the molecular biology of cutaneous T-cell lymphoma and developed techniques for molecular diagnosis of cutaneous T-cell lymphoma and T-cell mediated skin diseases. As the former Director of Dermatology at the Fox Chase Cancer Center in Philadelphia, PA (2000-2010), he created and directed clinical care programs in skin cancer, chemotherapy-associated skin toxicities and wound care along with a clinical trial program testing topical therapies for skin cancer treatment, prevention and supportive oncology. Dr. Lessin currently serves as Medical Director at KGL Skin Study Center in Broomall, PA, an independent clinical research facility providing comprehensive safety and efficacy testing of skin care and consumer products in human subjects.
Dr. Lessin is a co-founder of the Cutaneous Lymphoma Foundation. Since its inception in 1998, he has served on its Board of Directors in various capacities including Board President (2011-2013).
Dr. Lessin and his family live in Philadelphia, PA.